Products Affected - Description
Sodium acetate, American Regent
2 mEq/mL, 20 mL vial (NDC 00517-2096-25)
4 mEq/mL, 50 mL vial (NDC 00517-5023-25)
Sodium acetate, Fresenius Kabi
4 mEq/mL, 100 mL vial (NDC 63323-0032-61) - discontinued
Reason for the Shortage
- American Regent has sodium acetate on shortage due to manufacturing delays.
- American Regent has discontinued sodium acetate 2 mEq/mL 100 mL vials.
- Fresenius Kabi discontinued sodium acetate in September 2015.
- Hospira has sodium acetate available.
Sodium acetate, Hospira
2 mEq/mL, 20 mL vial (NDC 00409-7299-73)
2mEq/mL, 50 mL vial (NDC 00409-3299-05)
2mEq/mL, 100 mL vial (NDC 00409-3299-06)
Estimated Resupply Dates
American Regent has all sodium acetate presentations on back order and the company cannot estimate a release date.
September 18, February 6, 2015; December 19, October 20, August 15 and 7, May 7, February 10, 2014; November 6, September 18, July 25, May 23, April 1, March 11 and 1, January 30 and 4, 2013; December 24, November 6, October 9 and 4, September 12, August 22, July 31 and 3, June 18, May 22 and 2, April 25 and 17, March 29 and 12, February 15 and 1, January 5, 2012; December 13, November 23 and 2, October 31 and 20, September 29, August 30, 17, 8, and 4, July 22, June 16 and 1, 2011; April 29, 18, and 8, 2011, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins